RA Capital Management »

Aura Biosciences shares owned by RA Capital Management

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $18M 2.5M 7.10

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Aura Biosciences

TCG Crossover Management
Suvretta Capital Management
Frazier Life Sciences Management
Long Focus Capital Management
Adage Capital Partners GP
Caligan Partners
Vanguard Capital Management
BlackRock
OrbiMed Advisors
Medicxi Ventures Management
Nantahala Capital Management
Jupiter Topco
RA Capital Management
Balyasny Asset Management
Franklin Resources

View all funds holding Aura Biosciences